ATARA BIOTHERAPEUTICS, INC. Total Liabilities
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Total Liabilities of $58.02 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-12
- 2026-06-30: Liabilities $58.02M.
- 2026-03-31: Liabilities $57.31M.
- 2025-12-31: Liabilities $58.74M.
- 2025-09-30: Liabilities $66.80M.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $58.02M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $57.31M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $58.74M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $66.80M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $71.94M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $117.11M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $206.38M 10-K · filed 2026-03-16 |
| 2024-09-30 | $233.25M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $228.15M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $263.58M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $264.74M 10-K · filed 2025-03-07 |
| 2023-09-30 | $239.63M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $238.99M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $237.12M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $249.78M 10-K · filed 2024-03-28 |
| 2022-09-30 | $181.20M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $178.64M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $172.96M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $188.51M 10-K · filed 2023-02-08 |
| 2021-09-30 | $139.78M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $125.25M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $130.60M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $125.78M 10-K · filed 2022-02-28 |
| 2020-09-30 | $51.60M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $46.99M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $46.73M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $52.16M 10-K · filed 2021-03-01 |
| 2019-09-30 | $46.34M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $41.87M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $40.79M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $52.98M 10-K · filed 2020-02-27 |
| 2018-09-30 | $39.89M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $40.21M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $33.92M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $39.91M 10-K · filed 2019-02-26 |
| 2017-09-30 | $23.74M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $23.01M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $8.60M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $10.18M 10-K · filed 2018-02-27 |
| 2016-09-30 | $14.21M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $10.57M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $9.14M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $9.88M 10-K · filed 2017-03-09 |
| 2015-09-30 | $6.63M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $11.85M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $3.72M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $2.94M 10-K · filed 2016-03-04 |
| 2014-09-30 | $2.58M 10-Q · filed 2014-11-12 |
| 2013-12-31 | $1.75M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |